Taro’s interim CEO Gandhi
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) has appointed Abhay Gandhi to the position of Interim Chief Executive Officer, effective January 1, 2017.
The Interim CEO will serve in this role during the period from Kal Sundaram’s departure at the end of this year until the arrival in April 2017 of Uday Baldota, Taro’s recently appointed CEO.
Gandhi currently serves as the CEO of the Sun Pharmaceutical Industries Ltd. North America operations, a position he succeeded from Sundaram.
Taro’s Board of Directors has also nominated Gandhi to its Board. fii-news.com